Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
June 18, 2013 -- Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership with the Center for Blood Research (CBR) at the University of British Columbia. BoXin LaiTe and Heracles use their ability to validate the commercial and clinical of novel discoveries made at the CBR and accelerate their development for the China market. More details....
Help employers find you! Check out all the jobs and post your resume.
